Skip to main content
TipRanks
Go Ultimate75% OFF

Bausch + Lomb Corporation (S2L) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

S2L Analyst Ratings

Moderate Buy
10Ratings
4Buy5Hold1Sell
Based on 10 analysts giving stock ratings to Bausch + Lomb Corporation in the past 3 months

S2L Stock 12 Month Forecast

€20.22▲(7.53% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Bausch + Lomb Corporation in the last 3 months. The average price target is EUR 20.22 with a high forecast of EUR 24.56 and a low forecast of EUR 16.38. The average price target represents a 7.53% change from the last price of EUR 18.80.
Highest Price Target€24.56Average Price Target€20.22Lowest Price Target€16.38

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:S2L
Price TargetArticle
Barclays€21.83→€24.56buy30.65%UpsideReiterated11/17/26
H.C. Wainwright€19.10→€20.01hold6.46%UpsideDowngraded11/02/26
RBC Capital€19.10→€20.92buy11.30%UpsideAssigned10/29/26
Citi€19.10→€20.92buy11.30%UpsideReiterated10/29/26
Leerink Partners€21.83→€23.65buy25.82%UpsideReiterated10/29/26
J.P. Morgan€14.56→€20.01hold6.46%UpsideReiterated10/29/26
Deutsche Bank €14.56→€18.19hold-3.22%DownsideReiterated10/29/26
Bank of America Securities―sell―Reiterated10/29/26
Stifel Nicolaus€14.56→€17.29hold-8.06%DownsideReiterated10/29/26
Wells Fargo€16.38hold-12.90%DownsideReiterated09/18/26
UBS€19.10→€20.92buy11.30%UpsideInitiated07/30/26
Evercore ISI€15.47hold-17.74%DownsideReiterated07/30/26
Needham―hold―Reiterated07/29/26
Goldman Sachs€19.10hold1.62%UpsideReiterated07/14/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
PTGXProtagonist Therapeutics
IMUXImmunic
IVAInventiva
PALIPalisade Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bausch + Lomb Corporation

3 Months
Douglas Miehm
Douglas MiehmRBC Capital
Success Rate18/30 ratings generated profit
60%
Average Return
+2.57%

Copying Douglas Miehm's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +2.57% per trade.

1 Year
Success Rate10/12 ratings generated profit
83%
Average Return
+13.30%

Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +13.30% per trade.

2 Years
Success Rate9/12 ratings generated profit
75%
Average Return
+12.91%

Copying Joanne Wuensch's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +12.91% per trade.

S2L Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for S2L
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy578108
Hold77855
Sell11111
Strong Sell00000
total1315171614

In the current month, S2L has received 8 Buy Ratings, 5 Hold Ratings, and 1 Sell Ratings. S2L average Analyst price target in the past 3 months is 20.22.

S2L Financial Forecast

€-1€-0.5€0€0.5€1Q1 2026Q3 2026Q4 2026
High€0.40
Consensus€0.34
Low€0.29

S2L Earnings Forecast

Next quarter’s earnings estimate for S2L is EUR 0.34 with a range of EUR 0.29 to EUR 0.40. The previous quarter’s EPS was EUR 0.31. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€1.1B€1.2B€1.2B€1.3B€1.4BQ1 2026Q3 2026Q4 2026
High€1.37B
Consensus€1.35B
Low€1.34B

S2L Sales Forecast

Next quarter’s sales forecast for S2L is EUR 1.35B with a range of EUR 1.34B to EUR 1.37B. The previous quarter’s sales results were EUR 1.25B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

S2L Stock Forecast FAQ

What is DE:S2L’s average 12-month price target, according to analysts?
Based on analyst ratings, Bausch + Lomb Corporation’s 12-month average price target is €20.22.
What is DE:S2L’s upside potential, based on the analysts’ average price target?
Bausch + Lomb Corporation has 7.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Bausch + Lomb Corporation a Buy, Sell or Hold?
Bausch + Lomb Corporation has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 5 hold ratings and 1 sell ratings.
What is Bausch + Lomb Corporation’s share price target?
The average share price target for Bausch + Lomb Corporation is €20.22. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €24.56, and the lowest forecast is €16.38. The average share price target represents a 7.53% increase from the current price of €18.8.
What do analysts say about Bausch + Lomb Corporation?
Bausch + Lomb Corporation’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of Bausch + Lomb Corporation?
To buy shares of DE:S2L, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.